In charge of the health sector for the Ministry of Industry (Direction Générale des Entreprises), we support innovation and industrial development projects led by companies in the health sector, particularly in Auvergne-Rhône-Alpes and Hauts-de-France.  The “France 2030” investment plan aims to strengthen our biomedical research capacity, invest in tomorrow’s healthcare fields (biotherapy and biomanufacturing of innovative therapies, digital health, emerging infectious diseases and CBRN threats, medical devices), make France the leading country in Europe for clinical trials, accelerate and simplify market access, and support the growth and industrialization of companies in the sector.